Frequency: Once per day (subcutaneous)
The treatment takes less than 10 minutes and treats a wide variety of common running injuries
The standard dosing range for injectable BPC-157 falls between 0.25 and 0.50 mg (250 to 500 micrograms) administered once or twice daily
It interacts with multiple systems in the body including the nitric oxide (NO) pathway, growth hormone receptors, and angiogenic regulators like VEGF (vascular endothelial growth factor) to promote tissue repair, reduce oxidative stress, and modulate the immune response
In conclusion, as shown in Fig S1, the activation of eNOS by BPC 157 is mediated through multiple regulation processes including the promotion of VEGFR2 activation and endocytosis, the activation of positive regulator AKT, the reduction of the interaction of negative regulator Cav-1 with eNOS